Black Diamond Therapeutics Inc
BDTX
NASDAQ
Biotechnology
$2.02
USD
0.00 (0.00%)
At close: Aug 14, 2026, 4:00 PM EDT
Market Cap $116.92M
Volume 330.3K
Peer Comparison Table
(1/4) | ||||||
|---|---|---|---|---|---|---|
CADL | Candel Therapeutics Inc | $864.59M | - | - | - | |
XGN | Exagen Inc | $159.21M | - | +20.8% | - | |
CBUS | Cibus Inc | $148.47M | - | -9.8% | - | |
VTVT | vTv Therapeutics Inc | $125.18M | 55.59 | +216600.0% | - | |
GNLX | Genelux Corp | $121.97M | - | - | - | |
INDP | Indaptus Therapeutics Inc | $120.04M | - | - | - | |
BDTX | Black Diamond Therapeutics Inc | $116.92M | - | - | - | |
ANIX | Anixa Biosciences Inc | $109.89M | - | - | - | |
COYA | Coya Therapeutics Inc | $109.55M | - | +115.4% | - | |
INO | Inovio Pharmaceuticals Inc | $93.07M | - | - | - |
Top Peer by Growth
vTv Therapeutics Inc
+216600.0% YoY Revenue
Lowest P/E Ratio
vTv Therapeutics Inc
55.59x P/E
Best 1-Year Return
Candel Therapeutics Inc
+68.2% Return